Australia markets open in 6 hours 17 minutes

Inspire Medical Systems, Inc. (INSP)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
149.92-6.28 (-4.02%)
As of 11:43AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.61B
Enterprise value 4.17B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.99
Price/book (mrq)8.47
Enterprise value/revenue 7.32
Enterprise value/EBITDA -142.54

Trading information

Stock price history

Beta (5Y monthly) 1.39
52-week change 3-32.36%
S&P500 52-week change 315.95%
52-week high 3330.00
52-week low 3123.27
50-day moving average 3157.46
200-day moving average 3240.17

Share statistics

Avg vol (3-month) 3726.53k
Avg vol (10-day) 3462.61k
Shares outstanding 529.52M
Implied shares outstanding 629.52M
Float 828.96M
% held by insiders 11.57%
% held by institutions 199.87%
Shares short (14 Nov 2023) 41.32M
Short ratio (14 Nov 2023) 41.49
Short % of float (14 Nov 2023) 45.06%
Short % of shares outstanding (14 Nov 2023) 44.47%
Shares short (prior month 12 Oct 2023) 41.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023

Profitability

Profit margin -5.75%
Operating margin (ttm)-8.79%

Management effectiveness

Return on assets (ttm)-5.34%
Return on equity (ttm)-6.46%

Income statement

Revenue (ttm)570.19M
Revenue per share (ttm)19.56
Quarterly revenue growth (yoy)40.40%
Gross profit (ttm)341.74M
EBITDA -47.3M
Net income avi to common (ttm)-32.77M
Diluted EPS (ttm)-1.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)464.21M
Total cash per share (mrq)15.72
Total debt (mrq)25.17M
Total debt/equity (mrq)4.63%
Current ratio (mrq)8.14
Book value per share (mrq)18.51

Cash flow statement

Operating cash flow (ttm)26.66M
Levered free cash flow (ttm)12.41M